XVIVO created an animation that provides a 30,000-foot overview of neurophysiological signaling in the human brain to help the team at Neuralink describe the science that underpins their brain-machine interface development.
SB-030 A NOVEL MATRIX REGULATOR
By
admin
XVIVO partnered with Symic Bio to develop an animation that demonstrates the potential efficacy of their molecule, SB-030. SB-030 is delivered to the vessel during a vascular procedure and binds to any exposed matrix inhibiting platelet response to any injury.
PROTAC PLATFORM
By
admin
The biopharmaceutical company Arvinas Inc. has taken a unique approach to develop investigational therapies for hard-to-treat diseases, including cancers. XVIVO, in collaboration with Wyant Simboli and their client, Arvinas Inc., helped communicate the unconventional mechanism of action for a new class of drugs that engage the body’s own protein disposal system to target cancers and other difficult-to-treat diseases.
HEART SCIENCES MYOVISTA WAVELET ECG TECHNOLOGY
By
Jordan Maire
XVIVO partnered with Heart Sciences to develop an animation describing their MyoVista Wavelet ECG technology that can detect changes in the heart from CHD and other diseases before symptoms appear.
STRATTICE RECONSTRUCTIVE TISSUE MATRIX
By
Jordan Maire
Strattice™ Reconstructive Tissue Matrix is a tissue matrix used to support soft tissue regeneration post-surgery. …
QUANTUM CELL EXPANSION SYSTEM
By
Jordan Maire
Terumo BCT partnered with XVIVO to develop a program for one of their devices, the Quantum Cell Expansion System.
MEDTRONIC SACRAL NEUROMODULATION
By
Jordan Maire
Medtronic Sacral Neuromodulation is a treatment option for patients with overactive bladder (OAB). This 3D medical animation shows dysfunction to the neurological pathway that is believed to contribute to urinary control.
TELEFLEX MICROLAPAROSCOPY PLATFORM
By
Jordan Maire
Teleflex Medical developed a new microlaparoscopic platform that utilizes instrumentation with a smaller diameter shaft. …
GINTUIT™
By
admin
Organogenesis partnered with XVIVO to help them bring their first product for dental surgery into market. GINTUIT™ (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen), is a cellular sheet that has been shown to predictably generate new and aesthetically appealing oral soft tissue.
BIOSTAGE CELLFRAME TECHNOLOGY
By
admin
About 456,000 new cases of esophageal cancer occur each year. In the United States alone, …